The role of tumor necrosis factor-alpha (TNF-α) in skeletal muscle regeneration: Studies in TNF-α(-/-) and TNF-α(-/-)/LT-α(-/-) mice

Journal of Histochemistry and Cytochemistry

Volumn 49, Issue 8, 2001, Pages 989-1001

  Collins, R A ^a   Grounds, M D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cytokine; Histology; Immunohistochemistry; Lymphotoxin ; Muscle regeneration; Null mice; Tumor necrosis factor

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MAST CELL; MOUSE; MUSCLE INJURY; MUSCLE REGENERATION; MUSCLE TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ANIMALIA;

EID: 0034923715     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540104900807     Document Type: Article

References (89)

1. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy
2. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy
3. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma
4. The role of tumor necrosis factor-α in muscle wasting disorders
5. Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines
6. Muscle spindles
7. Tumor necrosis, cachexia, shock and inflammation: A common mediator
8. Cytokine modulation by glucocorticoids: Mechanisms and actions in cellular studies
9. Cytokines in exertion-induced skeletal muscle injury
10. The production of cytokines by polymorphonuclear neutrophils
11. Selective expression of neurotrophin-3 messenger RNA in muscle spindles of the rat
12. Dystrophin gene, protein and cell biology
13. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies
14. Autocrine tumor necrosis factor (TNF) and lymphotoxin (LT) alpha differentially modulate cellular sensitivity to TNF/LT-alpha cytotoxicity in L929 cells
15. Interferons
16. Transforming growth factor-β and its receptors
17. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis
18. Type I IFN modulates innate and specific antiviral immunity
19. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity
20. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level
21. Physiological roles of matrix metalloproteinases: Implications for tumor growth and metastasis
22. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia
23. The role of cytotoxic effector molecules and cytokines in inflammatory myopathies
24. Tumor necrosis factor induces skeletal muscle protein breakdown in rats
25. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses
26. Muscle regeneration: Molecular aspects and therapeutic implications
27. Chemotaxis in myogenesis
28. TNF-α stimulates activation of pro-MMP2 in human skin through NF-κB mediated induction of MT1-MMP
29. Biphasic effects of interleukin-1 alpha on dermal fibroblasts: Enhancement of chemotactic responsiveness at low concentrations and of mRNA expression for collagenase at high concentrations
30. Inhibition of interferon gamma induced interleukin 12 production - A potential mechanism for the anti-inflammatory activities of tumor necrosis factor
31. Tumour necrosis factor-α gene expression in the tissues of normal mice
32. Novel, antigen-specific therapeutic approaches to autoimmune/inflammatory diseases
33. Proinflammatory cytokines regulate myogenic cell proliferation and fusion but have no impact on myotube protein metabolism or stress protein expression
34. Impaired preneoplastic changes and liver tumor formation in TNF receptor type I knockout mice
35. Tumour necrosis factor and lymphotoxin: Molecular aspects and role in tissue-specific autoimmunity
36. Revisiting the role of tumour necrosis factor α and the response to surgical injury and inflammation
37. Leukaemia inhibitory factor and other cytokines as factors influencing regeneration of skeletal muscle
38. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating muscle
39. Experimental skeletal muscle grafts as a model of regeneration
40. New developments in the role of cytokines and chemokines in inflammatory myopathies
41. Development and regeneration of muscle spindles in mammals and birds
42. Basal lamina development in chicken muscle spindles
43. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha
44. Intrinsic differences in MyoD and myogenin expression between primary cultures of SJL/J and BALB/c skeletal muscle
45. Extracellular matrix, growth factors, genetics: Their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle
46. Characterization of tumor necrosis factor-deficient mice
47. Effects of interferons on tumour necrosis factor alpha production from human keratinocytes
48. Cell proliferation in skeletal muscle following denervation or tenotomy
49. Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice. An autoradiographic study
50. The onset of myogenesis in denervated mouse skeletal muscle regenerating after injury
51. Age-related changes in replication of myogenic cells in mdx mice: Quantitative autoradiographic studies
52. Development of skeletal muscles in transforming growth factor-beta 1 (TGF-beta 1) nullmutant mice
53. Cellular differences in the regeneration of murine skeletal muscle: A quantitative histological study in SJL/J and BALB/c mice
54. Transforming growth factor-beta2 is elevated in skeletal muscle disorders
55. Quantitative morphology of mast cells in skeletal muscle of normal and genetically dystrophic mice
56. Exposure to acute stress induces brain interleukin-1beta protein in the rat
57. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease
58. Models of ensemble firing of muscle spindle afferents recorded during normal locomotion in cats
59. Endothelial cell activation during angiogenesis in freely transplanted skeletal muscles in mice and its relationship to the onset of myogenesis
60. The host environment determines strain-specific differences in the timing of skeletal muscle regeneration: Cross-transplantation studies between SJL/J and BALB/c mice
61. Pax7 is expressed in the capsules surrounding adult mouse neuromuscular spindles
62. Interleukin 1
63. Ultrastructural localization of tumour necrosis factor-alpha
64. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis
65. Role of interleukin-1 in stress responses. A putative neurotransmitter
66. Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice
67. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity
68. Interleukin-12
69. TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin
70. Expression of tumor necrosis factor-alpha in muscles of polymyositis
71. Cytokine expression profile in idiopathic inflammatory myopathies
72. Inflammatory cell response to acute muscle injury
73. Tumour necrosis factor-alpha
74. The biology of cachectin/tumor necrosis factor
75. Muscle wasting and IL-6
76. The pathophysiology of tumor necrosis factors
77. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions
78. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors
79. Lymphotoxins: From cytotoxicity to lymphoid organogenesis
80. Apoptosis mediated by the TNF-related cytokine and receptor families
81. Role of mast cells and basophils in innate and acquired immunity
82. "Bystander" damage of host muscle caused by implantation of MHC-compatible myogenic cells
83. Myotube formation is delayed but not prevented in MyoD-deficient skeletal muscle: Studies in regenerating whole muscle grafts of adult mice
84. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing
85. Initiation of liver growth by tumour necrosis factor: Deficient liver regeneration in mice lacking type I tumour necrosis factor receptor
86. Evidence that tumour necrosis factor participates in the regulation of muscle proteolysis during sepsis